- Home
- QNCX vs NCSM Comparison
QNCX vs NCSM Comparison
Compare QNCX & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- NCSM
- Stock Information
- Founded
- QNCX 2012
- NCSM 2006
- Country
- QNCX United States
- NCSM United States
- Employees
- QNCX N/A
- NCSM N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- NCSM Oilfield Services/Equipment
- Sector
- QNCX Health Care
- NCSM Energy
- Exchange
- QNCX Nasdaq
- NCSM Nasdaq
- Market Cap
- QNCX 85.9M
- NCSM 76.3M
- IPO Year
- QNCX 2019
- NCSM 2017
- Fundamental
- Price
- QNCX $1.65
- NCSM $42.59
- Analyst Decision
- QNCX Strong Buy
- NCSM
- Analyst Count
- QNCX 6
- NCSM 0
- Target Price
- QNCX $8.00
- NCSM N/A
- AVG Volume (30 Days)
- QNCX 263.4K
- NCSM 19.7K
- Earning Date
- QNCX 11-12-2025
- NCSM 10-29-2025
- Dividend Yield
- QNCX N/A
- NCSM N/A
- EPS Growth
- QNCX N/A
- NCSM N/A
- EPS
- QNCX N/A
- NCSM 4.71
- Revenue
- QNCX N/A
- NCSM $175,468,000.00
- Revenue This Year
- QNCX N/A
- NCSM $11.91
- Revenue Next Year
- QNCX N/A
- NCSM $7.63
- P/E Ratio
- QNCX N/A
- NCSM $9.04
- Revenue Growth
- QNCX N/A
- NCSM 19.31
- 52 Week Low
- QNCX $0.69
- NCSM $16.81
- 52 Week High
- QNCX $2.45
- NCSM $53.69
- Technical
- Relative Strength Index (RSI)
- QNCX 56.09
- NCSM 41.88
- Support Level
- QNCX $1.59
- NCSM $48.85
- Resistance Level
- QNCX $1.68
- NCSM $52.06
- Average True Range (ATR)
- QNCX 0.06
- NCSM 3.13
- MACD
- QNCX 0.01
- NCSM -1.04
- Stochastic Oscillator
- QNCX 69.57
- NCSM 4.64
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.